Method for radiolabeling proteins with technetium-99m
AssigneesNuc Med Inc., University Patents, Inc.
InventorsDavid R. Crockford, Buck A. Rhodes
Life of this patent
Estimating the term…
Loading patent…
AssigneesNuc Med Inc., University Patents, Inc.
InventorsDavid R. Crockford, Buck A. Rhodes
Estimating the term…
Proteins are radiolabeled with technetium-99m in a reducing environment comprising buffered stannous chloride wherein the tin utilized to form the stannous chloride is non-oxidized, the buffered stannous chloride is purged of oxygen and the buffer comprises an alkali metal biphthalate and an alkali metal tartrate. Proteins which have been preincubated with tin are radiolabeled with technetium-99m to form a strongly bonded, non-exchangeable radiolabeled tracer substance. The radiolabeling can be accomplished immediately after pretinning, or the pretinned proteins can be freeze-dried and the radiolabeling accomplished at some time in the future when the pretinned proteins are resolubilized in a saline solution of sodium pertechnetate - TC-99m. Pretinning can be accomplished in a reducing environment comprising stannous chloride buffered with an alkali metal biphthalate and an alkali metal tartrate, this solution having been purged of oxygen to assure that the stannous chloride is non-oxidized. When the pretinning proteins are freeze-dried, they can be utilized to prepare instant TC-99m labeling kits for use as radiopharmaceuticals.
The process for forming a reducing composition suitable for being radiolabeled with technetium-99m which comprises incubating a source of stannous ion with a protein in the presence of a buffering composition comprising a mixture of an alkali metal biphthalate and an alkali metal tartrate having a pH between about 4.5 and 8.5 for at least about 15 hours at a temperature wherein said protein is not denatured.
A diagnostic kit suitable for forming a composition to be administered to a human patient which comprises a first sterile package containing a source of stannous ion and a buffering composition comprising a mixture of an alkali metal biphthalate and an alkali metal tartrate having a pH between about 4.5 and 8.5 and a second sterile package containing a protein suitable for being radiolabeled with technetium-99m.
Dependencies are inferred from the claim text.